Unda S, Alonso PL: Malaria prevention with IPTp through pregnancy reduces neonatal mortality. PLoS One 2010, five:e9438. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL: An evaluation of your effects of intermittent sulfadoxinepyrimethamine therapy in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 1998, 92:141?50. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Broadhead RL: Malaria in pregnancy and its consequences for the infant in rural Malawi. Ann Trop Med Parasitol 1999, 93(Suppl 1):S25 33. WHO-MPAC: Malaria Policy Advisory Committee towards the WHO: conclusions and suggestions of September 2012 meeting. Malar J 2012, 11:424. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, Mosha FW, Greenwood B, Chandramohan D: Protective efficacy and security of 3 antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet 2009, 374:1521?532. Griffin JT, Cairns M, Ghani AC, Roper C, Schellenberg D, Carneiro I, Newman RD, Grobusch MP, Greenwood B, Chandramohan D, Gosling RD: Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) utilizing sulfadoxine-pyrimethamine and parasite resistance. PLoS One particular 2010, 5:e12618. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE: Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.Price of 4,6-Dibromopicolinic acid Clin Infect Dis 2011, 53:224?30.1411774-27-0 Price Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF: Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria.PMID:24103058 EMBO J 1998, 17:3807?815. Wang P, Study M, Sims PF, Hyde JE: Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an extra issue connected with folate utilization. Mol Microbiol 1997, 23:979?86. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D: Higher resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania as well as the emergence of dhps resistance mutation at Codon 581. PLoS One particular 2009, four:e4569. Raman J, Mauff K, Muianga P, Mussa A, Maharaj R, Barnes KI: 5 years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out. PLoS 1 2011, six:e25992. Polski JM, Kimzey S, Percival RW, Grosso LE: Speedy and efficient processing of blood specimens for diagnostic PCR making use of filter paper and Chelex-100. Mol Pathol 1998, 51:215?17. Jelinek T, Ronn AM, Curtis J, Duraisingh MT, Lemnge MM, Mhina J, Bygbjerg IC, Warhurst DC: High prevalence of mutations within the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania with no evidence of an association to clinical sulfadoxine/ pyrimethamine resistance. Trop Med Int Health 1997, 2:1075?079. University of Mayland School of Medicine: PCR-allele-specific restriction evaluation (ASRA): protocols for Plasmodium falciparum drug resistance mutation analyses. University of Mayland; 2002. Accessed:10-5-2013. Schonfeld M, Barreto MI, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Loscher T: Molecular surveillance of drug-resistance associated mutations of Plasmodium f.